Signing the FDA-Required Mifepristone Agreement Form Did Not Meaningfully Raise Knowledge in Five-State Trial of 593 Patients
A randomized trial of 593 patients found the FDA-required mifepristone agreement form added little to what patients knew as the agency's safety review continues.
Medical Daily ·